Alteogen Healthcare

Alteogen Healthcare is the commercial-stage subsidiary of Alteogen, a prominent South Korean biotechnology company specializing in long-acting biobetters and subcutaneous drug delivery technologies. The healthcare division was established to lead the global sales, marketing, and distribution of the parent company's pharmaceutical portfolio, most notably Tergase, a recombinant human hyaluronidase. By leveraging Alteogen's proprietary Hybrozyme platform, the company aims to provide innovative solutions for drug delivery and specialty therapeutics. Alteogen Healthcare also manages the commercialization strategy for a robust pipeline of biosimilars targeting ophthalmology and oncology indications. The company is focused on building a comprehensive distribution network to expand its market presence in both domestic and international healthcare sectors.